Stent-Related Adverse Events >1 Year After Percutaneous Coronary Intervention-Reference-Cited by-同舟云学术

Stent-Related Adverse Events >1 Year After Percutaneous Coronary Intervention

Published:2020-02 Issue:6 Volume:75 Page:590-604
ISSN:0735-1097
Container-title:Journal of the American College of Cardiology
language:en
Short-container-title:Journal of the American College of Cardiology

Author:

Madhavan Mahesh V.,Kirtane Ajay J.,Redfors Björn,Généreux Philippe,Ben-Yehuda Ori,Palmerini Tullio,Benedetto Umberto,Biondi-Zoccai Giuseppe,Smits Pieter C.,von Birgelen Clemens,Mehran Roxana,McAndrew Thomas,Serruys Patrick W.,Leon Martin B.,Pocock Stuart J.,Stone Gregg W.

Funder

Abbott Vascular

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference30 articles.

1. Safety and efficacy of drug-eluting stents in women: a patient-level pooled analysis of randomised trials;Stefanini;Lancet,2013

2. Long-term safety of drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis;Palmerini;J Am Coll Cardiol,2015

3. Long-term (4- to 6-year) outcome of Palmaz-Schatz stenting: paucity of late clinical stent-related problems;Laham;J Am Coll Cardiol,1996

4. Beyond restenosis: five-year clinical outcomes from second-generation coronary stent trials;Cutlip;Circulation,2004

5. Stent thrombosis with drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis;Palmerini;Lancet,2012

Cited by 202 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rationale and design of INFINITY-SWEDEHEART: A registry-based randomized clinical trial comparing clinical outcomes of the sirolimus-eluting DynamX bioadaptor to the zotarolimus-eluting Resolute Onyx stent;American Heart Journal;2024-11

2. Pressure-responsive pH-triggered layer-by-layer coating of paclitaxel-eluting balloon catheters for instant high-dose drug delivery for percutaneous coronary artery intervention;Nano Research;2024-09-12

3. Long-term efficacy, safety and biocompatibility of a novel sirolimus eluting iron bioresorbable scaffold in a porcine model;Bioactive Materials;2024-09

4. How feasible is a cage-free solution for de novo coronary artery disease?;The Lancet;2024-09

5. Silencing of <italic>PCK1</italic> mitigates the proliferation and migration of vascular smooth muscle cells and vascular intimal hyperplasia by suppressing STAT3/DRP1-mediated mitochondrial fission;Acta Biochimica et Biophysica Sinica;2024-09-01